-
81
Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
Published 2018-02-01Get full text
Article -
82
Propagation of TDP-43 proteinopathy in neurodegenerative disorders
Published 2022-01-01Get full text
Article -
83
Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
Published 2022-09-01“…Due to the rise in the elderly population, age-dependent neurodegenerative disorders are becoming increasingly prevalent. …”
Get full text
Article -
84
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Published 2014-05-01“…Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and frontotemporal dementias (FTD), are considered distinct entities, however, there is increasing evidence of an overlap from the clinical, pathological and genetic points of view. …”
Get full text
Article -
85
Melatonin in Alzheimer's disease and other neurodegenerative disorders
Published 2006-05-01“…<p>Abstract</p> <p>Increased oxidative stress and mitochondrial dysfunction have been identified as common pathophysiological phenomena associated with neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). …”
Get full text
Article -
86
Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?
Published 2022-01-01“…A more extensive characterization of the relationship between delusions and delirium may help to understand whether delusions may constitute a risk factor for delirium and may ameliorate the management of both conditions in patients with neurodegenerative disorders.…”
Get full text
Article -
87
TLR-Mediated Signal Transduction and Neurodegenerative Disorders
Published 2021-10-01Get full text
Article -
88
Editorial: Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders
Published 2022-06-01Get full text
Article -
89
Social Cognition in Patients With Cerebellar Neurodegenerative Disorders
Published 2021-08-01Subjects: Get full text
Article -
90
Prions and Prion-Like Pathogens in Neurodegenerative Disorders
Published 2014-02-01“…They have been identified as self-replicating proteinaceous agents responsible for the onset of rare and fatal neurodegenerative disorders—known as transmissible spongiform encephalopathies, or prion diseases—which affect humans and other animal species. …”
Get full text
Article -
91
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Published 2020-04-01Subjects: Get full text
Article -
92
Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders
Published 2020-01-01Subjects: Get full text
Article -
93
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Published 2024-03-01“…Neuroinflammatory and neurodegenerative disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), traumatic brain injury (TBI) and Amyotrophic lateral sclerosis (ALS) are chronic major health disorders. …”
Get full text
Article -
94
Brain-Derived Neurotropic Factor in Neurodegenerative Disorders
Published 2022-05-01Subjects: Get full text
Article -
95
Effect of Refined Edible Oils on Neurodegenerative Disorders
Published 2023-07-01Get full text
Article -
96
An interactive review on the role of Tocotrienols in the neurodegenerative disorders
Published 2021“…Neurodegenerative disorders, such as Parkinson's and Alzheimer's disease, are claimed to be of major concern causing a significant disease burden worldwide. …”
Article -
97
Transposable elements in TDP-43-mediated neurodegenerative disorders.
Published 2012-01-01“…Elevated expression of specific transposable elements (TEs) has been observed in several neurodegenerative disorders. TEs also can be active during normal neurogenesis. …”
Get full text
Article -
98
Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders
Published 2020-06-01Subjects: Get full text
Article -
99
Need to improve clinical trials in rare neurodegenerative disorders
Published 2011-01-01“…The adoption of innovative statistical approaches in early Phase II trials might improve the screening of drugs in rare neurodegenerative disorders, but this implicates efforts from clinical researchers, statisticians, and regulatory people to the development of new strategies that should maintain rigorous scientific integrity together with a more ethical approach to human experimentations.…”
Get full text
Article -
100
Linking Puberty and the Gut Microbiome to the Pathogenesis of Neurodegenerative Disorders
Published 2022-10-01“…Due to the maturation of these fundamental systems, this is a period of development that is particularly sensitive to stressors, increasing susceptibility to neurodevelopmental and neurodegenerative disorders later in life. The gut microbiome plays a critical role in the regulation of stress and immune responses, and gut dysbiosis has been implicated in the development of neurodevelopmental and neurodegenerative disorders. …”
Get full text
Article